Japan Respiratory Device Market Insights Forecasts to 2033

• The Market is Growing at a CAGR of 8.95% from 2023 to 2033
• The Japan Respiratory Device Market Size is Expected to Hold a Significant Share by 2033

The Japan Respiratory Device Market is Anticipated to Hold a Significant Share by 2033, growing at a CAGR of 8.95% from 2023 to 2033.

Market Overview

Medical equipment intended to improve general respiratory function and help patients with breathing difficulties is known as a respiratory device. The management and treatment of illnesses including asthma, sleep apnea, and chronic obstructive pulmonary disease (COPD) depend heavily on this equipment, which includes ventilators, nebulizers, oxygen concentrators, and CPAP machines. Additionally, delivering therapeutic interventions, maintaining appropriate oxygen levels, and ensuring effective ventilation for patients with compromised respiratory systems are the main uses. By integrating cutting-edge technology, respiratory care devices improve patient comfort and offer crucial support, particularly for patients with acute respiratory distress and chronic respiratory diseases. Furthermore, the need for respiratory care devices is increasing in Japan as a result of the country's aging population, since respiratory conditions are more common in the elderly. The necessity for ongoing monitoring and treatment alternatives to improve the senior population's quality of life is driving market expansion.

Report Coverage

This research report categorizes the market for the Japan respiratory device market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan respiratory device market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan respiratory device market.

Driving Factors

The primary drivers driving the segment's growth are the rising incidence of respiratory conditions such hay fever and chronic obstructive pulmonary disease (COPD). Hay fever, the most common respiratory allergy in Japan, is brought on by cedar pollen that is dispersed throughout the nation. Additionally, In Japan, an estimated 5.3 million people suffer from COPD, according to a survey conducted by the health ministry and other sources. This high prevalence is one of the main factors propelling the Japanese respiratory device market. The need for sophisticated respiratory care equipment is growing as more people with COPD require them for efficient management and treatment. Furthermore, the need for respiratory care solutions is increasing due to Japan's aging population and rising pollution levels. Furthermore, one of the main factors driving market expansion in Japan is the rise in respiratory syncytial virus infections among youngsters. Additionally, the Japanese healthcare system is heavily burdened by respiratory syncytial virus. Consequently, it is projected that the rising prevalence of these illnesses will raise Japan's need for inhalers, driving the market's expansion throughout the projection period.

Restraining Factors

It is anticipated that the market growth will be constrained by the strict regulatory criteria for product clearance, which lengthen the time and expense of introducing new products. Furthermore, the adoption of modern respiratory care technology is anticipated to be hampered by the lack of resources and healthcare infrastructure in some areas, as well as financial limitations in developing nations.

Market Segmentation

The Japan respiratory device market share is classified into type and end user.

• The ICU ventilators segment is expected to hold a significant market share through the forecast period.

The Japan respiratory device market is segmented by type into ICU ventilators and portable/transportable ventilators. Among these, the ICU ventilators segment is expected to hold a significant market share through the forecast period. The market for ICU ventilators is expanding due to a number of factors, including the growing number of ventilator-equipped intensive care units, the rise in ICU admissions and re-admissions in developed nations, and the advantageous reimbursement environment.

• The home care settings segment is expected to dominate the Japan respiratory device market during the forecast period.       

Based on the end user, the Japan respiratory device market is divided into hospitals, home care settings, and ambulatory care centres. Among these, the home care settings segment is expected to dominate the Japan respiratory device market during the forecast period. Sleep apnea treatments are one of the primary markets for breathing devices used in home care. The growing usage of positive airway pressure devices to treat sleep apnea is primarily responsible for the growth of this market segment.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan respiratory device market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Dragerwerk AG
• Fisher & Paykel Healthcare Ltd
• Getinge AB
• Terumo Corporation
• GE Healthcare
• Koninklijke Philips NV
• Medtronic PLC
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In May 2024, the long-acting monoclonal antibody Beyfortus (nirsevimab), developed by AstraZeneca and Sanofi, has been approved in Japan for the prevention of respiratory syncytial virus (RSV)-induced lower respiratory tract disease (LRTD).

Market Segment

This study forecasts revenue at Japan, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Japan Respiratory Device Market based on the below-mentioned segments:

Japan Respiratory Device Market, By Type

• ICU ventilators
• Portable/Transportable Ventilators

Japan Respiratory Device Market, By End User

• Hospitals
• Home Care Settings
• Ambulatory Care Centres